These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

588 related articles for article (PubMed ID: 25677591)

  • 1. Aptamers and their applications in nanomedicine.
    Sun H; Zu Y
    Small; 2015 May; 11(20):2352-64. PubMed ID: 25677591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aptamers as Versatile Ligands for Biomedical and Pharmaceutical Applications.
    Guan B; Zhang X
    Int J Nanomedicine; 2020; 15():1059-1071. PubMed ID: 32110008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superior Performance of Aptamer in Tumor Penetration over Antibody: Implication of Aptamer-Based Theranostics in Solid Tumors.
    Xiang D; Zheng C; Zhou SF; Qiao S; Tran PH; Pu C; Li Y; Kong L; Kouzani AZ; Lin J; Liu K; Li L; Shigdar S; Duan W
    Theranostics; 2015; 5(10):1083-97. PubMed ID: 26199647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aptamers in targeted nanotherapy.
    Mathew A; Maekawa T; Sakthikumar D
    Curr Top Med Chem; 2015; 15(12):1102-14. PubMed ID: 25866269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of aptamers for in vivo molecular imaging and theranostics.
    Bouvier-Müller A; Ducongé F
    Adv Drug Deliv Rev; 2018 Sep; 134():94-106. PubMed ID: 30125606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aptamer applications for targeted cancer therapy.
    Barbas AS; Mi J; Clary BM; White RR
    Future Oncol; 2010 Jul; 6(7):1117-26. PubMed ID: 20624124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Theranostic nanomedicine.
    Lammers T; Aime S; Hennink WE; Storm G; Kiessling F
    Acc Chem Res; 2011 Oct; 44(10):1029-38. PubMed ID: 21545096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aptamers: molecular tools for medical diagnosis.
    Ozalp VC; Kavruk M; Dilek O; Bayrac AT
    Curr Top Med Chem; 2015; 15(12):1125-37. PubMed ID: 25866272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aptamer-guided nanomedicines for anticancer drug delivery.
    Alshaer W; Hillaireau H; Fattal E
    Adv Drug Deliv Rev; 2018 Sep; 134():122-137. PubMed ID: 30267743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bispecific therapeutic aptamers for targeted therapy of cancer: a review on cellular perspective.
    Vandghanooni S; Eskandani M; Barar J; Omidi Y
    J Mol Med (Berl); 2018 Sep; 96(9):885-902. PubMed ID: 30056527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody-targeted nanoparticles for cancer treatment.
    Carter T; Mulholland P; Chester K
    Immunotherapy; 2016 Jul; 8(8):941-58. PubMed ID: 27381686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in aptamer-armed multimodal theranostic nanosystems for imaging and targeted therapy of cancer.
    Vandghanooni S; Eskandani M; Barar J; Omidi Y
    Eur J Pharm Sci; 2018 May; 117():301-312. PubMed ID: 29499349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aptamer-targeted oligonucleotide theranostics: a smarter approach for brain delivery and the treatment of neurological diseases.
    Sriramoju B; Kanwar R; Veedu RN; Kanwar JR
    Curr Top Med Chem; 2015; 15(12):1115-24. PubMed ID: 25866271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide- and aptamer-functionalized nanovectors for targeted delivery of therapeutics.
    Pangburn TO; Petersen MA; Waybrant B; Adil MM; Kokkoli E
    J Biomech Eng; 2009 Jul; 131(7):074005. PubMed ID: 19655996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleic acid aptamer-guided cancer therapeutics and diagnostics: the next generation of cancer medicine.
    Xiang D; Shigdar S; Qiao G; Wang T; Kouzani AZ; Zhou SF; Kong L; Li Y; Pu C; Duan W
    Theranostics; 2015; 5(1):23-42. PubMed ID: 25553096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aptamer nanomedicine for cancer therapeutics: barriers and potential for translation.
    Lao YH; Phua KK; Leong KW
    ACS Nano; 2015 Mar; 9(3):2235-54. PubMed ID: 25731717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The development and testing of aptamers for cancer.
    Barbas AS; White RR
    Curr Opin Investig Drugs; 2009 Jun; 10(6):572-8. PubMed ID: 19513946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aptamer for imaging and therapeutic targeting of brain tumor glioblastoma.
    Delač M; Motaln H; Ulrich H; Lah TT
    Cytometry A; 2015 Sep; 87(9):806-16. PubMed ID: 26189784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applications of Cancer Cell-Specific Aptamers in Targeted Delivery of Anticancer Therapeutic Agents.
    Kim M; Kim DM; Kim KS; Jung W; Kim DE
    Molecules; 2018 Apr; 23(4):. PubMed ID: 29617327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smart ligand: aptamer-mediated targeted delivery of chemotherapeutic drugs and siRNA for cancer therapy.
    Li X; Zhao Q; Qiu L
    J Control Release; 2013 Oct; 171(2):152-62. PubMed ID: 23777885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.